Sarah GJA Peeters
Sarah GJA Peeters
Verified email at oncology.ox.ac.uk
Title
Cited by
Cited by
Year
Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiation
L Dubois, S Peeters, NG Lieuwes, N Geusens, A Thiry, S Wigfield, F Carta, ...
Radiotherapy and Oncology 99 (3), 424-431, 2011
1762011
A comparative study of the hypoxia PET tracers [18F] HX4,[18F] FAZA, and [18F] FMISO in a preclinical tumor model
SGJA Peeters, CML Zegers, NG Lieuwes, W van Elmpt, J Eriksson, ...
International Journal of Radiation Oncology* Biology* Physics 91 (2), 351-359, 2015
1412015
TH-302 in combination with radiotherapy enhances the therapeutic outcome and is associated with pretreatment [18F] HX4 hypoxia PET imaging
SGJA Peeters, CML Zegers, R Biemans, NG Lieuwes, ...
Clinical Cancer Research 21 (13), 2984-2992, 2015
932015
Targeting carbonic anhydrase IX by nitroimidazole based sulfamides enhances the therapeutic effect of tumor irradiation: a new concept of dual targeting drugs
L Dubois, SGJA Peeters, SJA van Kuijk, A Yaromina, NG Lieuwes, ...
Radiotherapy and Oncology 108 (3), 523-528, 2013
752013
Current preclinical and clinical applications of hypoxia PET imaging using 2-nitroimidazoles
SG Peeters, CM Zegers, A Yaromina, W Van Elmpt, L Dubois, P Lambin
QJ Nucl Med Mol Imaging 59 (1), 39-57, 2015
492015
New ways to image and target tumour hypoxia and its molecular responses
LJ Dubois, R Niemans, SJA van Kuijk, KM Panth, NK Parvathaneni, ...
Radiotherapy and Oncology 116 (3), 352-357, 2015
462015
[18 F] VM4-037 microPET imaging and biodistribution of two in vivo CAIX-expressing tumor models
SGJA Peeters, L Dubois, NG Lieuwes, D Laan, M Mooijer, RC Schuit, ...
Molecular imaging and biology 17 (5), 615-619, 2015
332015
Preclinical assessment of efficacy of radiation dose painting based on intratumoral FDG-PET uptake
D Trani, A Yaromina, L Dubois, M Granzier, SGJA Peeters, R Biemans, ...
Clinical Cancer Research 21 (24), 5511-5518, 2015
292015
A phase 1 ‘window-of-opportunity’trial testing evofosfamide (TH-302), a tumour-selective hypoxia-activated cytotoxic prodrug, with preoperative chemoradiotherapy in oesophageal …
RTHM Larue, L Van De Voorde, M Berbée, WJC van Elmpt, LJ Dubois, ...
BMC cancer 16 (1), 1-8, 2016
212016
Dosimetric evaluation of radionuclides for VCAM-1-targeted radionuclide therapy of early brain metastases
N Falzone, NL Ackerman, L de la Fuente Rosales, MA Bernal, X Liu, ...
Theranostics 8 (1), 292, 2018
102018
(In) organic anions as carbonic anhydrase inhibitors
N Krall, F Pretto, W Decurtins, SU Rehman, ZH Chohan, F Gulnaz, ...
Angew Chem Int Ed Engl 53, 4231-5, 2014
72014
Inhibition of the archaeal β-class (Cab) and γ-class (Cam) carbonic anhydrases
N Krall, F Pretto, W Decurtins, SU Rehman, ZH Chohan, F Gulnaz, ...
Angew Chem Int Ed Engl 53, 4231-5, 2014
52014
PV-0039: Outcome of elderly NSCLC patients treated with isotoxic RT dose-escalation using IMRT (NCT01166204)
J Van Loon, D De Ruysscher, S Peeters, K Verhoeven, G Bootsma, ...
Radiotherapy and Oncology 127, S15-S16, 2018
12018
Abstract B144: Hypoxia imaging with [18F] HX4 PET compared with [18F] FMISO and [18F] FAZA: From preclinical to clinical studies.
S Peeters, C Zegers, N Lieuwes, W van Elmpt, F Hoebers, H Sharifi, ...
Molecular Cancer Therapeutics 12 (11 Supplement), B144-B144, 2013
12013
Microbubbles Containing Lysolipid Enhance Ultrasound‐Mediated Blood–Brain Barrier Breakdown In Vivo
O Vince, S Peeters, VA Johanssen, M Gray, S Smart, NR Sibson, E Stride
Advanced Healthcare Materials 10 (3), 2001343, 2021
2021
PO-1024: Fractionated RT is equally effective but less toxic than SBRT for central early-stage NSCLC
M Leenders, S Peeters, J Van Loon, A Van Baardwijk, B Reymen, ...
Radiotherapy and Oncology 152, S546, 2020
2020
PO-1573: First clinical experience with model-based selection for breast cancer proton therapy
K Verhoeven, G Vilches-Freixas, K Limpens, J Mannens, K Van der Klugt, ...
Radiotherapy and Oncology 152, S852-S853, 2020
2020
Prospectively registered acute toxicity in breast cancer patients undergoing adjuvant intensity modulated proton therapy
K Verhoeven, T Opbroek, G Vilches-Freixas, K Limpens, J Mannens, ...
European Journal of Cancer 138, S85, 2020
2020
Antibody targeted ultrasound-responsive nanodroplets for the therapy of brain metastases: A pre-clinical study
O Vince, L Bau, S Peeters, M Gray, L Richards, S Smart, N Sibson, ...
The Journal of the Acoustical Society of America 144 (3), 1852-1852, 2018
2018
Monte Carlo evaluation of radionuclides for early brain metastases targeting
N Falzone, NL Ackerman, L De La Fuente Rosales, MA Bernal, S Peeters, ...
Wiley, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–20